AR056908A1 - Los oligonucleotidos y sus usos - Google Patents
Los oligonucleotidos y sus usosInfo
- Publication number
- AR056908A1 AR056908A1 ARP050104073A AR056908A1 AR 056908 A1 AR056908 A1 AR 056908A1 AR P050104073 A ARP050104073 A AR P050104073A AR 056908 A1 AR056908 A1 AR 056908A1
- Authority
- AR
- Argentina
- Prior art keywords
- bone
- oligonucleotides
- osteogenesis
- animal
- area
- Prior art date
Links
- 108091034117 Oligonucleotide Proteins 0.000 title abstract 5
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 title abstract 4
- 210000000988 bone and bone Anatomy 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 230000011164 ossification Effects 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 230000002188 osteogenic effect Effects 0.000 abstract 2
- 241000251539 Vertebrata <Metazoa> Species 0.000 abstract 1
- 230000007547 defect Effects 0.000 abstract 1
- 230000007812 deficiency Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 230000003239 periodontal effect Effects 0.000 abstract 1
- 230000009897 systematic effect Effects 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se presentan oligonucleotidos con capacidad para disimular la osteogénesis en animales vertebrados, inclusive en pacientes humanos. Estos oligonucleotidos osteogénicos pueden ser utilizados en una amplia gama de procedimientos clínicos para reemplazar y restituir defectos oseos y periodontales, o para facilitar el implante exitoso de protesis y los procedimientos de distraccion en huesos. Esta invencion proporciona métodos para la generacion de hueso en un área de un animal que presenta deficiencia de tejido esquelético. Estos consisten en la administracion local o sistemática en el animal de una composicion que consiste en uno o más oligonucleotidos osteogénicos, en un vehículo farmacéuticamente aceptable. La composicion es administrada en una entidad efectiva para inducir la osteogénesis en el área del hueso. Reivindicacion 1: Uso de un oligonucleotido compuesto de unos 14 a 100 nucleotidos para la elaboracion de un medicamento destinado a inducir la osteogénesis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP050104073 AR056908A1 (es) | 2005-09-27 | 2005-09-27 | Los oligonucleotidos y sus usos |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ARP050104073 AR056908A1 (es) | 2005-09-27 | 2005-09-27 | Los oligonucleotidos y sus usos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR056908A1 true AR056908A1 (es) | 2007-11-07 |
Family
ID=38734789
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050104073 AR056908A1 (es) | 2005-09-27 | 2005-09-27 | Los oligonucleotidos y sus usos |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR056908A1 (es) |
-
2005
- 2005-09-27 AR ARP050104073 patent/AR056908A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR058359A1 (es) | Combinaciones | |
| CY1121447T1 (el) | Συνθεσεις για αυξηση δραστηριοτητας τελομερασης | |
| ATE374597T1 (de) | Mikrokugeln zur aktiven embolisierung | |
| AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
| DE60028666D1 (de) | Verwendung von Fettgewebe-abgeleiteten Stromalen Zellen zur Differenzierung in Chondrozyten und ihre Verwendung zur Reparatur von Knorpelgewebe | |
| Huang et al. | Low-level diode laser therapy reduces lipopolysaccharide (LPS)-induced bone cell inflammation | |
| BRPI0512583A (pt) | composições e métodos de produção das mesmas, de liberação de agente ativo para e através do tecido da epiderme de pessoa ou animal e de tratamento de paciente que sofre de onicomicose, de psorìase de unha e de infecções | |
| Moslemi et al. | Outcomes of alveolar ridge preservation with recombinant human bone morphogenetic protein-2: a systematic review | |
| Pabst et al. | Influence of porcine-derived collagen matrix on endothelial progenitor cells: an in vitro study | |
| Yudell et al. | Bone gap healing in the dog using recombinant human bone morphogenetic protein-2 | |
| WO2004087065A3 (en) | Compositions for induction of a therapeutic response | |
| ITFI20030058A1 (it) | Formulazioni farmaceutiche contenenti tiazolidinedioni | |
| BR0313954A (pt) | Composição de cerâmica biocompatìvel, dispositivo médico, método para fabricar uma composição de cerâmica biocompatìvel, implantes médico e ortopédico, material de enchimento dental ou implante dental, veìculo de droga para liberação de droga no corpo de um paciente, uso da composição de cerâmica biocompatìvel, método para gerar calor in vivo no corpo de um paciente para propósitos terapêuticos, e, método terapêutico | |
| AR044200A1 (es) | Composicion de fondaparinux sodico de alta pureza ,un procedimiento de preparacion de esta composicion y composiciones farmaceuticas que la contienen como principio activo | |
| TW200633978A (en) | 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists | |
| ES2244361T1 (es) | Uso del acetato de anecortave para la proteccion de la agudeza visual en pacientes con degeneracion macular asociada a la edad. | |
| BRPI0407178A (pt) | Composição farmacêutica osteogênica | |
| ES2167853T3 (es) | N-aril 2-hidroxi alquilamidas. | |
| DE60031016D1 (de) | Verwendung von Antiseptika zur Herstellung von Arzneimitteln zur Prophylaxe und Behandlung von Entzündungen im Korperinneren des Menschen | |
| AR056908A1 (es) | Los oligonucleotidos y sus usos | |
| BR0315609A (pt) | Método de tratar, prevenir, modificar ou controlar dor e composição farmacêutica | |
| RU2005131578A (ru) | Аплидин для лечения множественной миеломы | |
| ECSP034632A (es) | Uso de compuestos del 6-dimetilaminometil-1-fenil-ciclohexaco sustituido en la terapia de la incontinencia urinaria | |
| Mainard | Sustitutos óseos | |
| Wu et al. | Interdisciplinary management of mandibular intraosseous haemagioma |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |